DIVA Laboratories, Ltd (GTSM:4153) agreed to acquire GeneTouch Corp., Ltd from shareholders in stock on July 17, 2014. Under the terms of agreement, DIVA Laboratories will issue 1 share for every 1.45 shares of GeneTouch. on November 14, 2014, DIVA Laboratories revised stock-swap ratio to acquire 1.65 common shares of GeneTouch through exchange of 1 share of DIVA Laboratories.

As of January 9, 2015, the swap date of January 20, 2015 was announced. DIVA and GeneTouch announced that the respective board of directors approved the consolidation on June 11, 2015.